StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

RGENBearishEarningsnews
Materiality pending

Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates

May 2, 2024, 12:33 PM EDT1 sourcesAI-analyzed

AI summary

What happened, with direct paths to the underlying reporting

- Repligen reported Q1 EPS of 28 cents, missing estimates, with revenues down 17.2%. - Base business revenues declined 9.4%, but chromatography franchise saw slight improvement. - Repligen expects revenues of $620-$650 million for 2024, with adjusted EPS of $1.42-$1.49. - Guidance includes adjusted gross margin of 49%-50% and adjusted operating margin of 13%-14%. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

  • Repligen reported Q1 EPS of 28 cents, missing estimates, with revenues down 17.2%.
  • Base business revenues declined 9.4%, but chromatography franchise saw slight improvement.
  • Repligen expects revenues of $620-$650 million for 2024, with adjusted EPS of $1.42-$1.49.
  • Guidance includes adjusted gross margin of 49%-50% and adjusted operating margin of 13%-14%.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.